LB Pharmaceuticals Inc (LBRX) Misses Q2 EPS by 93c

LB Pharmaceuticals Inc (NASDAQ: LBRX) reported Q2 EPS of ($1.71), $0.93 worse than the analyst estimate of ($0.78).

For earnings history and earnings-related data on LB Pharmaceuticals Inc (LBRX) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02
• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance